ArticleBMC geriatrics2026
Pillbox and patient-oriented manual interventions to improve medication knowledge, attitudes, and practices among older adults with multimorbidity in Shanghai, China.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMultimorbidity and polypharmacy are major challenges for older adults with multimorbidity (OAM) in China, yet demand-side interventions remain limited. This study aimed to assess the effectiveness of pillbox (PB) and patient-oriented manual (POM) interventions in improving medication knowledge (MK), attitudes (MA), and practices (MP) in Shanghai, China.
methodsA quasi-experimental pre–post study with a control group was conducted in 11 community health service centers in Jinshan District, Shanghai, between August 2023 and February 2024. Eligible older adults were recruited by family doctor teams, which implemented the intervention primarily using two tools: the PB and the POM. Outcomes included MK, MA, and MP. Intervention effects and heterogeneity across participant characteristics were examined using propensity score matched difference-in-differences (PSM-DID) models.
resultsA total of 1,406 OAM participated. After the intervention, the proportion rated as “good” increased from 29.6% to 57.1% for MK, 24.5% to 48.8% for MA, and 47.1% to 73.9% for MP. PSM-DID analyses showed significant intervention effects for MK (OR = 3.14), MA (OR = 2.38), and MP (OR = 3.01). Heterogeneity analyses showed stronger effects on MK among participants covered by urban and rural resident insurance (P = 0.043). For MP, effects weakened with increasing age (P = 0.044) but strengthened with increasing medication burden, with the strongest effects observed at moderate levels of polypharmacy (P = 0.012).
conclusionPB and POM interventions significantly improved MK, MA, and MP among OAM. Variation in intervention effects across participant characteristics underscored the need for tailored, patient-centered strategies integrated into routine family doctor services to promote rational medication use.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.